Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLH-2109 in Patients With Endometriosis
NCT07015268Phase 3Active, not recruiting
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Jun 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linzagolix in endometriosis, sponsored by Kissei Pharmaceutical Co., Ltd.. Started Jun 2025; status: active, not recruiting.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07015268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07015268.